What you will do: Design and execution of quantitative and qualitative research (including PROs, preference studies, patient interviews, etc) to incorporate patient perspectives into clinical research and real-world evidence studies across the product lifecycle to support regulatory approval, product labeling, value demonstration, and market access activities; Understanding patient insights and experiences with disease and treatment, through the measurement of outcomes that matter most to patients, including symptoms of disease, effects of treatment, and their impact on how patients feel and function; Execution of gap analyses, patient interviews, and/or reviews of the literature and PRO labels, to select and/or develop appropriate patient-reported measures or other COAs for clinical trials in accordance with FDA and EMA guidance; Collaboration with cross-functional partners on COA endpoint strategy; Leading the preparation of the COA components of regulatory briefing books, clinical trial protocols, statistical analysis plans, clinical study reports, regulatory filing documents, and HTA submissions; Collaboration with study statisticians on the analysis and interpretation of COA data, including assessments of clinically meaningful change; Development and execution of publication plans (abstract, posters, and manuscripts) and preparation of internal and external-facing presentations of patient-centered research findings; Ad hoc support of HEOR indication leads with real-word evidence generation activities such as natural history, burden of illness, treatment patterns, or other outcomes research studies; Management of relationships and budgets with vendors to ensure timely completion of high quality projects; Building strong relationships with internal partners and ensuring continuous and consistent communication regarding HEOR projects; Compliance with all applicable laws, Agios policies, regulations and regulatory guidelines governing commercial and scientific interactions with healthcare professionals, payers, advocacy and other business partners. What you bring: Master's or doctoral degree in health services research, sociology, psychology, psychometrics, public health, or related field; At least 7 years of pharmaceutical/biotechnology industry, consulting, or academic experience, at least 5 years of which has been specifically focused on patient-centered research; Demonstrated technical and strategic excellence in designing, conducting, and interpreting quantitative and qualitative patient-centered research; Knowledge of the drug development process, PRO label claims, and regulatory guidance as it relates to patient-centered research, including the FDA's patient-focused drug development (PFDD) initiative; Strong knowledge of the process for developing and validating outcome measures, methods for determination of clinically meaningful change thresholds, and clinical trial endpoint strategy; Experience with application of PRO data to regulatory, health economic and access activities; Ability to lead multiple projects simultaneously across a variety of therapeutic areas; Excellent written and oral communication skills; Strong interpersonal skills and ability to collaborate on cross-functional teams; Ability to interface with multiple external stakeholders, including patients, caregivers, clinicians, regulators, and payers; Ability to navigate ambiguous, complex, and difficult situations; Ability to travel approximately 10% of the time Concerned that you don't check off every box in the requirements listed above?